Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ashwinkrish
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ashwinkrish
-
Prikvačeni tweet
My team is expanding! We are looking for someone interested in working on
#leukemia, using#genomics, molecular biology and cell biology techniques to join us as an R.A., so please help us spread the word!https://external-careers.jobs.unsw.edu.au/cw/en/job/499078/research-assistant …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Feb 4 is
#WorldCancerDay
2020. Let's all work together to tackle this scourge that we have yet to fully overcome. Perseverance and commitment can only succeed with sufficient funding, so please continue supporting research #Workingtogether@TCRNetwork@UNSWMedicine@CancerSPHEREpic.twitter.com/TDMCSOJo1S
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ashwin Unnikrishnan proslijedio/la je Tweet
The
#ISEH2020 McCulloch & Till Award Winner is Mark Dawson!@MAFD110 is a clinician-scientist group leader at the Peter MacCallum Cancer Centre in Australia.@TheDawsonLab studies epigenetic regulation in normal and malignant haematopoiesis. Learn more: http://ow.ly/xLPO50y7rNs pic.twitter.com/abdqYi3J1R
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ashwin Unnikrishnan proslijedio/la je Tweet
Congratulations to Harvey Lodish
@WhiteheadInst,@MAFD110 (Mark Dawson)@PeterMacRes and Jennifer@TrowbridgeLab@jacksonlab, the 2020 recipients of the Donald Metcalf, Till and McCulloch and Janet Rowley awards, respectively, of@ISEHSociety. Looking fwd to your presentations!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ashwin Unnikrishnan proslijedio/la je Tweet
One of the hardest things to figure out as a PI, especially a young PI, is "when to hold em and when to fold em" with respect to appealing/revising a paper with tough reviews. A few thoughts
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I wanted to highlight this very important thread. I urge everyone to have a read
#sciencehttps://twitter.com/purton_louise/status/1216855086195826689 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thoughts and constructive comments welcome. Please feel free to message or email me
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy to present
@biorxivpreprint pre-print of our latest findings on#RNA#splicing in#AML. This is the first from my independent lab#newPI and was led by my grad student Govardhan, plus wonderful collaborators: https://doi.org/10.1101/2020.01.10.895714 …@UNSWMedicine@UNSW_POWCS@jasonwwongPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ashwin Unnikrishnan proslijedio/la je Tweet
Impressive dataset of 1300 AML&MDS genomes & transcriptomes by
@leukaemielabor &@CMullighan. A bit surprising: only 5 genes mutated per pat - median for targeted NGS is 3-4 already. Noncoding regions not analyzed yet-a lot of exciting insights probably still hidden there!#ASH19pic.twitter.com/CdE962ZvHx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ashwin Unnikrishnan proslijedio/la je Tweet
Last but not least- we had to wait for the final day of
#ASH19 for positive Ph3 data in AML. CC-486 (oral azacitidine) maintenance improves OS (but doesn’t increase cure rate) of older AML pts in CR. Interesting option for pts who got induction but then can’t proceed to alloSCTpic.twitter.com/ileijn17xB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A powerful message made so well.https://twitter.com/KharasLab/status/1204073288323997702 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For those packing for
#ASH19....so put away that winter jacket,@Lachy_Sydhttps://twitter.com/DrChrisHourigan/status/1202279210372534278 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This group photo has come out well! Kudos to those who put up the environmentally conscious decorations (big props to Nicole and Bonnie). Welcome, to the newcomers, and looking forward to a new year (and a new decade!)
@UNSW_POWCS@TCRNetworkhttps://twitter.com/DrCFord/status/1201391908439805952 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ashwin Unnikrishnan proslijedio/la je Tweet
Three
#ASH19 abstracts from the MLL focus on the growing potential of genetics to define clinically relevant subclasses of AML and MDS using#WholeGenomeSequencing and#MachineLearning.@ASH_hematology https://www.mll.com/en/news/magazine/scientific-reports/aml-and-mds-the-ever-expanding-potential-of-genetics-to-define-clinically-relevant-subclasses.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ashwin Unnikrishnan proslijedio/la je Tweet
Fascinating pre-print in
@biorxivpreprint on hematopoiesis in long-lived naked-mole rats: https://www.biorxiv.org/content/10.1101/859454v1 … More quiescent HSCs than in mice and no sign of some key hematopoietic TFs like RUNX1, GFI1B, GFI1, etc.pic.twitter.com/IfPBjEo0Km
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ashwin Unnikrishnan proslijedio/la je Tweet
Excited to share our study on genomic analysis of histiocytosis neoplasms in
@NatureMedicine. >250 patients from@MSKCC and reference centers in France, Belgium, Spain, (plus histiocytosis patients worldwide via MSK's Make-An-IMPACT):https://www.nature.com/articles/s41591-019-0653-6 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Ashwin Unnikrishnan proslijedio/la je Tweet
Our study is out
@NatureComms! Want to identify proteins interacting with your favorite RNA (even if its low abundance) or its specific regions? Try incPRINT, our new RNA-centric technology that does not rely on RNA pull-downs and mass spectrometry.https://www.nature.com/articles/s41467-019-13235-w …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ashwin Unnikrishnan proslijedio/la je Tweet
What AML subtypes should be prioritized in BET bromodomain inhibitors trials to impair LSCs? Check our latest report out now in Leukemia Research!
#leusm@LeukemiaRF@Institut_IRSL@Univ_Paris@HopSaintLouishttps://clicktime.symantec.com/36ok8XGsbZTmZDPCmt1Sf2G6H2?u=https%3A%2F%2Fauthors.elsevier.com%2Fa%2F1a4wmX17obpY7 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ashwin Unnikrishnan proslijedio/la je Tweet
Such an exciting time: work we began over a decade ago to understand the fundamental biology of hemoglobin switching, which highlighted BCL11A, has now led to multiple promising therapeutic avenues for
#SickleCell and#Thalassemia!@DFBC_PedCarehttps://twitter.com/AndyBiotech/status/1197520820769361921 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
